[Phosphofructokinase and aldolase activity of myocardial and liver tissues under conditions of catecholamine biosynthesis depression].
D000818:Animals; D001921:Brain / Q000201:enzymology; D002395:Catecholamines / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004794:Enzyme Repression / Q000187:drug effects; D004837:Epinephrine / Q000032:analysis; D005634:Fructose-Bisphosphate Aldolase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology*; D008297:Male; D009206:Myocardium / Q000201:enzymology*; D009638:Norepinephrine / Q000032:analysis; D010732:Phosphofructokinase-1 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051381:Rats; D013859:Thiocarbamates / Q000494:pharmacology
D002395:Catecholamines; D013859:Thiocarbamates; D004295:Dihydroxyphenylalanine; D010732:Phosphofructokinase-1; D005634:Fructose-Bisphosphate Aldolase; D009638:Norepinephrine; D004837:Epinephrine
Aktyvnist' fosforruktokinazy ĭ al'dolazy tkanyn miokarda ĭ pechinky za umov pryhnichennia biosyntezu katekholaminiv.